Researchers, advocates meet in Sydney to discuss state of microbicide, HIV prevention research

"Three decades after the full onset of the global HIV tragedy, science appears to finally be developing preventative measures, including microbicides that would thwart infections in the first place, according to individuals at" the biennial International Microbicides Conference in Sydney, the Asia Sentinel writes. "Now, however, the challenge is to put the solution into the hands of those most susceptible to the disease," the news service adds (Ramakant, 4/17). Researchers, advocates and funders met this week at the conference "to discuss the state of HIV prevention research," a conference press release states.

Speaking at the meeting, "Professor John Kaldor of the Kirby Institute at the University of New South Wales, co-chair of the conference, noted, 'This is the first microbicide conference to take place in the context of knowing a microbicide works and knowing [pre-exposure prophylaxis (PrEP)] works,'" according to the press release. "Much of the research presented at the conference on Monday focused on the promise of PrEP, which involves HIV-negative people at risk for HIV using antiretroviral medications (ARVs) to reduce the risk of HIV infection," the press release notes, adding, "Other research presented at the conference on Monday looked at the biology of mucosal transmission of HIV and rectal microbicides" (4/17).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk